Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy. - Wikidata - awgldk - TriplyDB

Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.

Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.

http://www.wikidata.org/entity/Q31126675

about

Skeletal muscle water T2 as a biomarker of disease status and exercise effects in patients with Duchenne muscular dystrophy.Upper arm and cardiac magnetic resonance imaging in Duchenne muscular dystrophy.Quantifying fat replacement of muscle by quantitative MRI in muscular dystrophy.Respiratory magnetic resonance imaging biomarkers in Duchenne muscular dystrophy.1 H NMRS of carnosine combined with 31 P NMRS to better characterize skeletal muscle pH dysregulation in Duchenne muscular dystrophy.MRI biomarkers of proximal nerve injury in CIDP.Skeletal muscle magnetic resonance biomarkers correlate with function and sentinel events in Duchenne muscular dystrophy.

P2860

Q36397532-5E613724-57FC-4DED-9B23-274805418406 Q37577885-86967E1E-38FA-4FEF-8E6C-6C7B47A5A1C4 Q39409381-51DD2205-32DA-4B7E-BEB1-30A5069B075C Q41510029-BC6FB36E-95DB-4937-AF6C-F335D13E49D3 Q47609659-C10F14CE-19D6-4EAC-8AE0-1231F832A79F Q49626870-775CC6A3-7392-4E97-8A58-C20790E5FABA Q55282480-E1FC3021-6EBD-4A5A-90A1-8B19E960B75F

P2860

Quantifying disease activity in fatty-infiltrated skeletal muscle by IDEAL-CPMG in Duchenne muscular dystrophy.

http://www.wikidata.org/entity/Q31126675

description

2016 nî lūn-bûn

@nan

2016 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Quantifying disease activity i ...... n Duchenne muscular dystrophy.

@ast

Quantifying disease activity i ...... n Duchenne muscular dystrophy.

@en

type

label

Quantifying disease activity i ...... n Duchenne muscular dystrophy.

@ast

Quantifying disease activity i ...... n Duchenne muscular dystrophy.

@en

prefLabel

Quantifying disease activity i ...... n Duchenne muscular dystrophy.

@ast

Quantifying disease activity i ...... n Duchenne muscular dystrophy.

@en

P1433

Q31126675-819BC5CE-2A90-4EC5-B5C6-4321646CA0EA

P1476

Q31126675-A52CCAC4-55ED-45B9-AF56-A24CC269FC73

P2093

Q31126675-54A36A84-A6E0-46EC-835B-F5FE9CE44183

Q31126675-869DDBB4-9D45-4C38-8ED1-32F38E6D933F

Q31126675-99C79BF8-263C-4567-97FF-6D290CAFC899

Q31126675-A280B7E9-0532-45AE-AAA5-D40DCFDBDE6F

Q31126675-AD0DD94B-83B2-4692-844C-0DEFE629EF39

Q31126675-F26086A4-C988-45FB-8EB4-E9C2F6049107

P2860

Q31126675-00C6EF53-9647-4305-8733-5EAEEC8FD2D9

Q31126675-05BC688D-6714-4D23-B6A8-613792C3914E

Q31126675-0C1D21B9-D46C-4D53-A358-06BD65380787

Q31126675-326DD941-9333-4865-A5AC-777B3C099E63

Q31126675-37876E07-E68D-4E04-827E-0DA5CD4A8528

Q31126675-39432A5A-2533-4479-940C-DD447C1B9717

Q31126675-399B4B78-50AF-4CF8-9FB5-AF5E7C656D6B

Q31126675-45C9C3B1-F6B9-42B5-93BD-F52CE4ED2187

Q31126675-4CE7E37E-C770-4110-9545-9F4A1E9C28E3

Q31126675-6E357DA6-70C5-4193-866D-EF12D062C4A6

P304

Q31126675-7FA3CF76-843B-43A4-8638-04D4997F6161

P31

Q31126675-9BC07327-1D07-4461-B9E3-4E47471E34A7

P356

Q31126675-9DD24AC2-9332-4EB5-A7EE-CD8168363CA0

P433

Q31126675-F54B64C5-467F-4B68-89C2-BF4EE1DE2A76

P478

Q31126675-33668859-4171-44C1-8B05-EEB9B9BFCA76

P577

Q31126675-0FFA0CC5-5A3A-4BF1-8031-FD8BA1B28ED0

P698

Q31126675-45850920-3588-4E03-8422-8B5F79A6BC8A

P932

Q31126675-9A03E30F-4618-40C3-9FF0-8B4B684A0644

P356

J.NMD.2016.07.013

P1433

Neuromuscular Disorders

P1476

Quantifying disease activity i ...... n Duchenne muscular dystrophy.

@en

P2093

Ami Mankodi

http://www.w3.org/2001/XMLSchema#string

Courtney A Bishop

http://www.w3.org/2001/XMLSchema#string

Kenneth H Fischbeck

http://www.w3.org/2001/XMLSchema#string

Rexford D Newbould

http://www.w3.org/2001/XMLSchema#string

Robert L Janiczek

http://www.w3.org/2001/XMLSchema#string

Sungyoung Auh

http://www.w3.org/2001/XMLSchema#string

P2860

Statistical methods for assessing agreement between two methods of clinical measurement

A global optimisation method for robust affine registration of brain images

Comparison of dixon and T1-weighted MR methods to assess the degree of fat infiltration in duchenne muscular dystrophy patients.

Chemical shift-based MRI to measure fat fractions in dystrophic skeletal muscle.

Validation of a generic approach to muscle water T2 determination at 3T in fat-infiltrated skeletal muscle.

Global T2 versus water T2 in NMR imaging of fatty infiltrated muscles: different methodology, different information and different implications.

Quantitative NMRI and NMRS identify augmented disease progression after loss of ambulation in forearms of boys with Duchenne muscular dystrophy.

Cramér-Rao bounds for three-point decomposition of water and fat.

Comparison of fat quantification methods: a phantom study at 3.0T.

Independent estimation of T*2 for water and fat for improved accuracy of fat quantification

P304

650-658

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.NMD.2016.07.013

http://www.w3.org/2001/XMLSchema#string

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P577

2016-07-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27593185

http://www.w3.org/2001/XMLSchema#string

P932

5062949

http://www.w3.org/2001/XMLSchema#string